June 28 (Reuters) - DermTech Inc DMTKW.PK :
* DERMTECH ANNOUNCES RESTRUCTURING TO PRIORITIZE GROWTH
OPPORTUNITIES AND STREAMLINE OPERATIONS
* DERMTECH INC - ANNUALIZED COST REDUCTION OF BETWEEN $25
MILLION
AND $30 MILLION
* DERMTECH INC - STRATEGIC FOCUS ON GROWING REVENUE FOR
DERMTECH
MELANOMA TEST (DMT)
* DERMTECH INC - CASH RUNWAY EXTENDED INTO Q1 OF 2025
* DERMTECH INC - WORKFORCE REDUCTION OF APPROXIMATELY 40
EMPLOYEES
* DERMTECH INC - ANTICIPATES A ONE-TIME RESTRUCTURING CHARGE
OF
APPROXIMATELY $2 MILLION IN Q2 OF 2023
* DERMTECH INC - HAD CASH, CASH EQUIVALENTS, RESTRICTED CASH
AND
SHORT-TERM MARKETABLE SECURITIES OF $108.4 MILLION AS OF MARCH
31, 2023
Source text for Eikon: ID:nBwbK5HVxa
Further company coverage: DMTKW.PK